Compare VIRC & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VIRC | CLNN |
|---|---|---|
| Founded | 1950 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.0M | 120.6M |
| IPO Year | N/A | N/A |
| Metric | VIRC | CLNN |
|---|---|---|
| Price | $6.55 | $6.31 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $32.67 |
| AVG Volume (30 Days) | 55.5K | ★ 318.3K |
| Earning Date | 12-08-2025 | 11-13-2025 |
| Dividend Yield | ★ 1.49% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.24 | N/A |
| Revenue | ★ $201,942,000.00 | $214,000.00 |
| Revenue This Year | $0.81 | N/A |
| Revenue Next Year | $4.56 | $87.58 |
| P/E Ratio | $27.71 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.01 | $2.28 |
| 52 Week High | $12.09 | $13.50 |
| Indicator | VIRC | CLNN |
|---|---|---|
| Relative Strength Index (RSI) | 37.68 | 37.94 |
| Support Level | $6.62 | $5.42 |
| Resistance Level | $6.93 | $7.03 |
| Average True Range (ATR) | 0.29 | 0.98 |
| MACD | -0.04 | -0.21 |
| Stochastic Oscillator | 37.24 | 16.61 |
Virco Manufacturing Corp is engaged in designing, production and distributing quality furniture for the commercial and education markets. The company manufactures an assortment of products, including mobile tables, mobile storage equipment, desks, computer furniture, chairs, and activity tables, folding chairs, and folding tables. Its primary furniture lines are constructed of tubular metal legs and frames, combined with wood and plastic tops, plastic seats and backs, upholstered seats and backs, and upholstered rigid polyethylene and polypropylene shells.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.